Protective effect of hydroxychloroquine on infections in patients with systemic lupus erythematosus: an observational study using the LUNA registry

ObjectivesInfection is a leading cause of death in patients with systemic lupus erythematosus (SLE). Alt hough hydroxychloroquine (HCQ) has been reported to inhibit infection, evidence from Asian populations remains insufficient. We investigated this effect in Japanese SLE patients.MethodsData from...

Full description

Bibliographic Details
Main Authors: Chiharu Hidekawa, Ryusuke Yoshimi, Yusuke Saigusa, Jun Tamura, Noriko Kojitani, Naoki Suzuki, Natsuki Sakurai, Yuji Yoshioka, Yumiko Sugiyama-Kawahara, Yosuke Kunishita, Daiga Kishimoto, Kana Higashitani, Yuichiro Sato, Takaaki Komiya, Hideto Nagai, Naoki Hamada, Ayaka Maeda, Naomi Tsuchida, Lisa Hirahara, Yutaro Soejima, Kaoru Takase-Minegishi, Yohei Kirino, Nobuyuki Yajima, Ken-ei Sada, Yoshia Miyawaki, Kunihiro Ichinose, Shigeru Ohno, Hiroshi Kajiyama, Shuzo Sato, Yasuhiro Shimojima, Michio Fujiwara, Hideaki Nakajima
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-09-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1227403/full
_version_ 1827854659507716096
author Chiharu Hidekawa
Ryusuke Yoshimi
Ryusuke Yoshimi
Yusuke Saigusa
Jun Tamura
Noriko Kojitani
Naoki Suzuki
Natsuki Sakurai
Yuji Yoshioka
Yumiko Sugiyama-Kawahara
Yosuke Kunishita
Daiga Kishimoto
Kana Higashitani
Yuichiro Sato
Takaaki Komiya
Hideto Nagai
Naoki Hamada
Ayaka Maeda
Naomi Tsuchida
Lisa Hirahara
Yutaro Soejima
Kaoru Takase-Minegishi
Yohei Kirino
Nobuyuki Yajima
Ken-ei Sada
Yoshia Miyawaki
Kunihiro Ichinose
Shigeru Ohno
Hiroshi Kajiyama
Shuzo Sato
Yasuhiro Shimojima
Michio Fujiwara
Hideaki Nakajima
author_facet Chiharu Hidekawa
Ryusuke Yoshimi
Ryusuke Yoshimi
Yusuke Saigusa
Jun Tamura
Noriko Kojitani
Naoki Suzuki
Natsuki Sakurai
Yuji Yoshioka
Yumiko Sugiyama-Kawahara
Yosuke Kunishita
Daiga Kishimoto
Kana Higashitani
Yuichiro Sato
Takaaki Komiya
Hideto Nagai
Naoki Hamada
Ayaka Maeda
Naomi Tsuchida
Lisa Hirahara
Yutaro Soejima
Kaoru Takase-Minegishi
Yohei Kirino
Nobuyuki Yajima
Ken-ei Sada
Yoshia Miyawaki
Kunihiro Ichinose
Shigeru Ohno
Hiroshi Kajiyama
Shuzo Sato
Yasuhiro Shimojima
Michio Fujiwara
Hideaki Nakajima
author_sort Chiharu Hidekawa
collection DOAJ
description ObjectivesInfection is a leading cause of death in patients with systemic lupus erythematosus (SLE). Alt hough hydroxychloroquine (HCQ) has been reported to inhibit infection, evidence from Asian populations remains insufficient. We investigated this effect in Japanese SLE patients.MethodsData from the Lupus Registry of Nationwide Institutions were used in this study. The patients were ≥20 years old and met the American College of Rheumatology (ACR) classification criteria revised in 1997. We defined “severe infections” as those requiring hospitalization. We analyzed the HCQ’s effect on infection suppression using a generalized estimating equation (GEE) logistic regression model as the primary endpoint and performed a survival analysis for the duration until the first severe infection.ResultsData from 925 patients were used (median age, 45 [interquartile range 35–57] years; female, 88.1%). GEE analysis revealed that severe infections were significantly associated with glucocorticoid dose (odds ratio [OR] 1.968 [95% confidence interval, 1.379–2.810], p<0.001), immunosuppressants (OR 1.561 [1.025–2.380], p=0.038), and baseline age (OR 1.043 [1.027–1.060], p<0.001). HCQ tended to suppress severe infections, although not significantly (OR 0.590 [0.329–1.058], p=0.077). Survival time analysis revealed a lower incidence of severe infections in the HCQ group than in the non-HCQ group (p<0.001). In a Cox proportional hazards model, baseline age (hazard ratio [HR] 1.029 [1.009–1.050], p=0.005) and HCQ (HR 0.322 [0.142–0.728], p=0.006) were significantly related to incidence.ConclusionHCQ may help extend the time until the occurrence of infection complications and tends to decrease infection rates.
first_indexed 2024-03-12T11:25:54Z
format Article
id doaj.art-250d87a98654495f8ee627fe93606299
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-03-12T11:25:54Z
publishDate 2023-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-250d87a98654495f8ee627fe936062992023-09-01T07:48:14ZengFrontiers Media S.A.Frontiers in Immunology1664-32242023-09-011410.3389/fimmu.2023.12274031227403Protective effect of hydroxychloroquine on infections in patients with systemic lupus erythematosus: an observational study using the LUNA registryChiharu Hidekawa0Ryusuke Yoshimi1Ryusuke Yoshimi2Yusuke Saigusa3Jun Tamura4Noriko Kojitani5Naoki Suzuki6Natsuki Sakurai7Yuji Yoshioka8Yumiko Sugiyama-Kawahara9Yosuke Kunishita10Daiga Kishimoto11Kana Higashitani12Yuichiro Sato13Takaaki Komiya14Hideto Nagai15Naoki Hamada16Ayaka Maeda17Naomi Tsuchida18Lisa Hirahara19Yutaro Soejima20Kaoru Takase-Minegishi21Yohei Kirino22Nobuyuki Yajima23Ken-ei Sada24Yoshia Miyawaki25Kunihiro Ichinose26Shigeru Ohno27Hiroshi Kajiyama28Shuzo Sato29Yasuhiro Shimojima30Michio Fujiwara31Hideaki Nakajima32Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, JapanDepartment of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, JapanClinical Laboratory Department, Yokohama City University Hospital, Yokohama, JapanDepartment of Biostatistics, Yokohama City University School of Medicine, Yokohama, JapanDepartment of Biostatistics, Yokohama City University School of Medicine, Yokohama, JapanDepartment of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, JapanDepartment of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, JapanDepartment of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, JapanDepartment of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, JapanDepartment of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, JapanDepartment of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, JapanCenter for Rheumatic Diseases, Yokohama City University Medical Center, Yokohama, JapanDepartment of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, JapanDepartment of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, JapanDepartment of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, JapanDepartment of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, JapanDepartment of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, JapanDepartment of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, JapanDepartment of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, JapanDepartment of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, JapanDepartment of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, JapanDepartment of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, JapanDepartment of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, JapanDivision of Rheumatology, Department of Medicine, Showa University School of Medicine, Tokyo, JapanDepartment of Clinical Epidemiology, Kochi Medical School, Kochi University, Nankoku, JapanDepartment of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, JapanDepartment of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, JapanCenter for Rheumatic Diseases, Yokohama City University Medical Center, Yokohama, JapanDepartment of Rheumatology and Applied Immunology, Faculty of Medicine, Saitama Medical University, Morohongo, Japan0Department of Rheumatology, Fukushima Medical University School of Medicine, Fukushima, Japan1Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Matsumoto, Japan2Department of Rheumatology, Yokohama Rosai Hospital, Yokohama, JapanDepartment of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, JapanObjectivesInfection is a leading cause of death in patients with systemic lupus erythematosus (SLE). Alt hough hydroxychloroquine (HCQ) has been reported to inhibit infection, evidence from Asian populations remains insufficient. We investigated this effect in Japanese SLE patients.MethodsData from the Lupus Registry of Nationwide Institutions were used in this study. The patients were ≥20 years old and met the American College of Rheumatology (ACR) classification criteria revised in 1997. We defined “severe infections” as those requiring hospitalization. We analyzed the HCQ’s effect on infection suppression using a generalized estimating equation (GEE) logistic regression model as the primary endpoint and performed a survival analysis for the duration until the first severe infection.ResultsData from 925 patients were used (median age, 45 [interquartile range 35–57] years; female, 88.1%). GEE analysis revealed that severe infections were significantly associated with glucocorticoid dose (odds ratio [OR] 1.968 [95% confidence interval, 1.379–2.810], p<0.001), immunosuppressants (OR 1.561 [1.025–2.380], p=0.038), and baseline age (OR 1.043 [1.027–1.060], p<0.001). HCQ tended to suppress severe infections, although not significantly (OR 0.590 [0.329–1.058], p=0.077). Survival time analysis revealed a lower incidence of severe infections in the HCQ group than in the non-HCQ group (p<0.001). In a Cox proportional hazards model, baseline age (hazard ratio [HR] 1.029 [1.009–1.050], p=0.005) and HCQ (HR 0.322 [0.142–0.728], p=0.006) were significantly related to incidence.ConclusionHCQ may help extend the time until the occurrence of infection complications and tends to decrease infection rates.https://www.frontiersin.org/articles/10.3389/fimmu.2023.1227403/fullsystemic lupus erythematosus (SLE)hydroxychloroquineinfectionAsianmulticenter registry
spellingShingle Chiharu Hidekawa
Ryusuke Yoshimi
Ryusuke Yoshimi
Yusuke Saigusa
Jun Tamura
Noriko Kojitani
Naoki Suzuki
Natsuki Sakurai
Yuji Yoshioka
Yumiko Sugiyama-Kawahara
Yosuke Kunishita
Daiga Kishimoto
Kana Higashitani
Yuichiro Sato
Takaaki Komiya
Hideto Nagai
Naoki Hamada
Ayaka Maeda
Naomi Tsuchida
Lisa Hirahara
Yutaro Soejima
Kaoru Takase-Minegishi
Yohei Kirino
Nobuyuki Yajima
Ken-ei Sada
Yoshia Miyawaki
Kunihiro Ichinose
Shigeru Ohno
Hiroshi Kajiyama
Shuzo Sato
Yasuhiro Shimojima
Michio Fujiwara
Hideaki Nakajima
Protective effect of hydroxychloroquine on infections in patients with systemic lupus erythematosus: an observational study using the LUNA registry
Frontiers in Immunology
systemic lupus erythematosus (SLE)
hydroxychloroquine
infection
Asian
multicenter registry
title Protective effect of hydroxychloroquine on infections in patients with systemic lupus erythematosus: an observational study using the LUNA registry
title_full Protective effect of hydroxychloroquine on infections in patients with systemic lupus erythematosus: an observational study using the LUNA registry
title_fullStr Protective effect of hydroxychloroquine on infections in patients with systemic lupus erythematosus: an observational study using the LUNA registry
title_full_unstemmed Protective effect of hydroxychloroquine on infections in patients with systemic lupus erythematosus: an observational study using the LUNA registry
title_short Protective effect of hydroxychloroquine on infections in patients with systemic lupus erythematosus: an observational study using the LUNA registry
title_sort protective effect of hydroxychloroquine on infections in patients with systemic lupus erythematosus an observational study using the luna registry
topic systemic lupus erythematosus (SLE)
hydroxychloroquine
infection
Asian
multicenter registry
url https://www.frontiersin.org/articles/10.3389/fimmu.2023.1227403/full
work_keys_str_mv AT chiharuhidekawa protectiveeffectofhydroxychloroquineoninfectionsinpatientswithsystemiclupuserythematosusanobservationalstudyusingthelunaregistry
AT ryusukeyoshimi protectiveeffectofhydroxychloroquineoninfectionsinpatientswithsystemiclupuserythematosusanobservationalstudyusingthelunaregistry
AT ryusukeyoshimi protectiveeffectofhydroxychloroquineoninfectionsinpatientswithsystemiclupuserythematosusanobservationalstudyusingthelunaregistry
AT yusukesaigusa protectiveeffectofhydroxychloroquineoninfectionsinpatientswithsystemiclupuserythematosusanobservationalstudyusingthelunaregistry
AT juntamura protectiveeffectofhydroxychloroquineoninfectionsinpatientswithsystemiclupuserythematosusanobservationalstudyusingthelunaregistry
AT norikokojitani protectiveeffectofhydroxychloroquineoninfectionsinpatientswithsystemiclupuserythematosusanobservationalstudyusingthelunaregistry
AT naokisuzuki protectiveeffectofhydroxychloroquineoninfectionsinpatientswithsystemiclupuserythematosusanobservationalstudyusingthelunaregistry
AT natsukisakurai protectiveeffectofhydroxychloroquineoninfectionsinpatientswithsystemiclupuserythematosusanobservationalstudyusingthelunaregistry
AT yujiyoshioka protectiveeffectofhydroxychloroquineoninfectionsinpatientswithsystemiclupuserythematosusanobservationalstudyusingthelunaregistry
AT yumikosugiyamakawahara protectiveeffectofhydroxychloroquineoninfectionsinpatientswithsystemiclupuserythematosusanobservationalstudyusingthelunaregistry
AT yosukekunishita protectiveeffectofhydroxychloroquineoninfectionsinpatientswithsystemiclupuserythematosusanobservationalstudyusingthelunaregistry
AT daigakishimoto protectiveeffectofhydroxychloroquineoninfectionsinpatientswithsystemiclupuserythematosusanobservationalstudyusingthelunaregistry
AT kanahigashitani protectiveeffectofhydroxychloroquineoninfectionsinpatientswithsystemiclupuserythematosusanobservationalstudyusingthelunaregistry
AT yuichirosato protectiveeffectofhydroxychloroquineoninfectionsinpatientswithsystemiclupuserythematosusanobservationalstudyusingthelunaregistry
AT takaakikomiya protectiveeffectofhydroxychloroquineoninfectionsinpatientswithsystemiclupuserythematosusanobservationalstudyusingthelunaregistry
AT hidetonagai protectiveeffectofhydroxychloroquineoninfectionsinpatientswithsystemiclupuserythematosusanobservationalstudyusingthelunaregistry
AT naokihamada protectiveeffectofhydroxychloroquineoninfectionsinpatientswithsystemiclupuserythematosusanobservationalstudyusingthelunaregistry
AT ayakamaeda protectiveeffectofhydroxychloroquineoninfectionsinpatientswithsystemiclupuserythematosusanobservationalstudyusingthelunaregistry
AT naomitsuchida protectiveeffectofhydroxychloroquineoninfectionsinpatientswithsystemiclupuserythematosusanobservationalstudyusingthelunaregistry
AT lisahirahara protectiveeffectofhydroxychloroquineoninfectionsinpatientswithsystemiclupuserythematosusanobservationalstudyusingthelunaregistry
AT yutarosoejima protectiveeffectofhydroxychloroquineoninfectionsinpatientswithsystemiclupuserythematosusanobservationalstudyusingthelunaregistry
AT kaorutakaseminegishi protectiveeffectofhydroxychloroquineoninfectionsinpatientswithsystemiclupuserythematosusanobservationalstudyusingthelunaregistry
AT yoheikirino protectiveeffectofhydroxychloroquineoninfectionsinpatientswithsystemiclupuserythematosusanobservationalstudyusingthelunaregistry
AT nobuyukiyajima protectiveeffectofhydroxychloroquineoninfectionsinpatientswithsystemiclupuserythematosusanobservationalstudyusingthelunaregistry
AT keneisada protectiveeffectofhydroxychloroquineoninfectionsinpatientswithsystemiclupuserythematosusanobservationalstudyusingthelunaregistry
AT yoshiamiyawaki protectiveeffectofhydroxychloroquineoninfectionsinpatientswithsystemiclupuserythematosusanobservationalstudyusingthelunaregistry
AT kunihiroichinose protectiveeffectofhydroxychloroquineoninfectionsinpatientswithsystemiclupuserythematosusanobservationalstudyusingthelunaregistry
AT shigeruohno protectiveeffectofhydroxychloroquineoninfectionsinpatientswithsystemiclupuserythematosusanobservationalstudyusingthelunaregistry
AT hiroshikajiyama protectiveeffectofhydroxychloroquineoninfectionsinpatientswithsystemiclupuserythematosusanobservationalstudyusingthelunaregistry
AT shuzosato protectiveeffectofhydroxychloroquineoninfectionsinpatientswithsystemiclupuserythematosusanobservationalstudyusingthelunaregistry
AT yasuhiroshimojima protectiveeffectofhydroxychloroquineoninfectionsinpatientswithsystemiclupuserythematosusanobservationalstudyusingthelunaregistry
AT michiofujiwara protectiveeffectofhydroxychloroquineoninfectionsinpatientswithsystemiclupuserythematosusanobservationalstudyusingthelunaregistry
AT hideakinakajima protectiveeffectofhydroxychloroquineoninfectionsinpatientswithsystemiclupuserythematosusanobservationalstudyusingthelunaregistry